ATE323693T1 - Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen - Google Patents

Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen

Info

Publication number
ATE323693T1
ATE323693T1 AT01981239T AT01981239T ATE323693T1 AT E323693 T1 ATE323693 T1 AT E323693T1 AT 01981239 T AT01981239 T AT 01981239T AT 01981239 T AT01981239 T AT 01981239T AT E323693 T1 ATE323693 T1 AT E323693T1
Authority
AT
Austria
Prior art keywords
treatment
pain
calcium channel
type calcium
channel antagonists
Prior art date
Application number
AT01981239T
Other languages
English (en)
Inventor
Bipinchandra Chaudhari
Marc Chapdelaine
Greg Hostetler
Lucius Kemp
John Mccauley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of ATE323693T1 publication Critical patent/ATE323693T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01981239T 2000-11-06 2001-10-31 Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen ATE323693T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0004053A SE0004053D0 (sv) 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain

Publications (1)

Publication Number Publication Date
ATE323693T1 true ATE323693T1 (de) 2006-05-15

Family

ID=20281713

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01981239T ATE323693T1 (de) 2000-11-06 2001-10-31 Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen

Country Status (9)

Country Link
US (1) US6815447B2 (de)
EP (1) EP1339706B1 (de)
JP (1) JP2004513125A (de)
AT (1) ATE323693T1 (de)
AU (1) AU2002212894A1 (de)
DE (1) DE60118956T2 (de)
ES (1) ES2261496T3 (de)
SE (1) SE0004053D0 (de)
WO (1) WO2002036586A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040259866A1 (en) * 1998-06-30 2004-12-23 Snutch Terrance P. Calcium channel blockers comprising two benzhydril moieties
WO2003099284A1 (en) 2002-05-22 2003-12-04 Amgen Inc. Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
MXPA05001456A (es) * 2002-08-08 2005-06-06 Amgen Inc Ligandos del receptor vanilloide y su uso en tratamientos.
US7419984B2 (en) * 2002-10-17 2008-09-02 Cell Therapeutics, Inc. Pyrimidines and uses thereof
CA2507100C (en) 2002-11-21 2012-10-09 Chiron Corporation 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
JP4691041B2 (ja) * 2003-11-20 2011-06-01 チルドレンズ ホスピタル メディカル センター Ｇｔｐアーゼ阻害剤および使用方法
US7301022B2 (en) 2005-02-15 2007-11-27 Amgen Inc. Vanilloid receptor ligands and their use in treatments
WO2006105670A1 (en) * 2005-04-08 2006-10-12 Neuromed Pharmaceuticals Ltd. Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
US8362021B2 (en) * 2006-05-11 2013-01-29 Zalicus Pharmaceuticals Ltd. Method for increasing the bioavailability of benzhydryl piperazine containing compounds
CA2675558A1 (en) 2007-02-06 2008-08-14 Novartis Ag Pi 3-kinase inhibitors and methods of their use
BR112012021656A2 (pt) * 2010-03-04 2017-02-07 Merck Sharp & Dohme composto, uso do mesmo, e, composição farmacêutica
MX2012010188A (es) * 2010-03-04 2012-10-03 Merck Sharp & Dohme Inhibidores de catecol o-metil transferasa y su uso en el tratamiento de transtornos psicoticos.
EP2542076B1 (de) 2010-03-04 2021-01-13 Merck Sharp & Dohme Corp. Hemmer der catechol-o-methyl-transferase und ihre verwendung bei der behandlung psychotischer störungen
US8409560B2 (en) 2011-03-08 2013-04-02 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
US8591944B2 (en) 2011-03-08 2013-11-26 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
PE20141581A1 (es) 2011-09-27 2014-11-14 Novartis Ag 3-pirmidin-4-il-oxazolidin-2-onas como inhibidores de la idh mutante
UY34632A (es) 2012-02-24 2013-05-31 Novartis Ag Compuestos de oxazolidin- 2- ona y usos de los mismos
US9296733B2 (en) 2012-11-12 2016-03-29 Novartis Ag Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
EA028033B1 (ru) 2013-03-14 2017-09-29 Новартис Аг 3-пиримидин-4-ил-оксазолидин-2-оны в качестве ингибиторов мутантного idh

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB794043A (en) * 1955-06-03 1958-04-30 Ici Ltd New quinoline derivatives
BR9909666A (pt) 1998-03-26 2001-09-11 Japan Tobacco Inc Derivados de amida e antagonistas de nociceptina

Also Published As

Publication number Publication date
EP1339706A1 (de) 2003-09-03
JP2004513125A (ja) 2004-04-30
DE60118956D1 (de) 2006-05-24
SE0004053D0 (sv) 2000-11-06
DE60118956T2 (de) 2007-03-15
WO2002036586A1 (en) 2002-05-10
US6815447B2 (en) 2004-11-09
US20040058945A1 (en) 2004-03-25
AU2002212894A1 (en) 2002-05-15
ES2261496T3 (es) 2006-11-16
EP1339706B1 (de) 2006-04-19

Similar Documents

Publication Publication Date Title
ATE323693T1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
ATE296094T1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
CA2366932A1 (en) Cyclic protein tyrosine kinase inhibitors
DE60135732D1 (de) Topoisomerasehemmern zur behandlung von chirurgischen verklebungen
ATE284690T1 (de) Antithrombotische diamine
DE502005008058D1 (de) Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen
ATE457027T1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
DE60035057D1 (de) CD40 Antagonist zur Behandlung von Psoriasis
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60204232D1 (de) Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
SE0302139D0 (sv) Novel compounds
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
SE0004054D0 (sv) N-type calcium channel antagonists for the treatment of pain
SE9802208D0 (sv) Novel compounds
YU13301A (sh) Muskarinski agonisti i antagonisti
SE0003476D0 (sv) Compounds
SE0303280D0 (sv) Novel compounds
ATE421502T1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
DE60026883D1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
SE9802209D0 (sv) Novel compounds
SE0004055D0 (sv) N-type calcium channel antagonists for the treatment of pain

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties